| 1 |
33596797 | The Therapeutic Effects of Dihydroartemisinin on Cisplatin-Resistant Gastric Cancer Cells. | 2022 |
2 |
| 2 |
33561488 | N-alkyl triphenylvinylpyridinium conjugated dihydroartemisinin perturbs mitochondrial functions resulting in enhanced cancer versus normal cell toxicity. | 2021 Mar |
1 |
| 3 |
34104103 | Dihydroartemisinin inhibits activation of the AIM2 inflammasome pathway and NF-κB/HIF-1α/VEGF pathway by inducing autophagy in A431 human cutaneous squamous cell carcinoma cells. | 2021 |
1 |
| 4 |
34205996 | Dihydroartemisinin Inhibits mTORC1 Signaling by Activating the AMPK Pathway in Rhabdomyosarcoma Tumor Cells. | 2021 Jun 1 |
5 |
| 5 |
34619345 | Dihydroartemisinin ameliorates retinal vascular dysfunction in diabetes mellitus via the FASN/Kmal-mTOR/SREBP1 feedback loop. | 2021 Dec |
3 |
| 6 |
31931362 | Dihydroartemisinin inhibits the proliferation of IgAN mesangial cells through the mTOR signaling pathway. | 2020 Mar |
3 |
| 7 |
32831913 | Dihydroartemisinin inhibits the migration of esophageal cancer cells by inducing autophagy. | 2020 Oct |
1 |
| 8 |
33658929 | Dihydroartemisinin Inhibits the Proliferation of Esophageal Squamous Cell Carcinoma Partially by Targeting AKT1 and p70S6K. | 2020 |
3 |
| 9 |
30557609 | DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin. | 2019 Feb 1 |
1 |
| 10 |
30599894 | Antimalarial Dihydroartemisinin triggers autophagy within HeLa cells of human cervical cancer through Bcl-2 phosphorylation at Ser70. | 2019 Jan |
2 |
| 11 |
31383247 | Dihydroartemisinin inhibits HepG2.2.15 proliferation by inducing cellular senescence and autophagy. | 2019 Aug |
1 |
| 12 |
31390552 | Dihydroartemisinin suppresses glycolysis of LNCaP cells by inhibiting PI3K/AKT pathway and downregulating HIF-1α expression. | 2019 Sep 15 |
1 |
| 13 |
31762815 | Dihydroartemisinin Induces Endothelial Cell Autophagy through Suppression of the Akt/mTOR Pathway. | 2019 |
4 |
| 14 |
28713965 | Dihydroartemisinin and gefitinib synergistically inhibit NSCLC cell growth and promote apoptosis via the Akt/mTOR/STAT3 pathway. | 2017 Sep |
1 |
| 15 |
25799586 | Dihydroartemisinin inhibits glucose uptake and cooperates with glycolysis inhibitor to induce apoptosis in non-small cell lung carcinoma cells. | 2015 |
4 |
| 16 |
23929438 | Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells. | 2014 Jan |
3 |
| 17 |
24462866 | Dihydroartemisinin potentiates the anticancer effect of cisplatin via mTOR inhibition in cisplatin-resistant ovarian cancer cells: involvement of apoptosis and autophagy. | 2014 Feb 14 |
3 |
| 18 |
22993204 | Dihydroartemisinin ameliorates inflammatory disease by its reciprocal effects on Th and regulatory T cell function via modulating the mammalian target of rapamycin pathway. | 2012 Nov 1 |
10 |